These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 8625136)

  • 41. Statistical analysis of relation between plasma methotrexate concentration and toxicity in high-dose methotrexate therapy of childhood nonHodgkin lymphoma.
    Tsurusawa M; Gosho M; Mori T; Mitsui T; Sunami S; Kobayashi R; Fukano R; Tanaka F; Fujita N; Inada H; Koh K; Takimoto T; Saito A; Fujimoto J; Nakazawa A; Horibe K;
    Pediatr Blood Cancer; 2015 Feb; 62(2):279-284. PubMed ID: 25359701
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity.
    Al-Turkmani MR; Law T; Narla A; Kellogg MD
    Clin Chem; 2010 Dec; 56(12):1792-4. PubMed ID: 21119035
    [No Abstract]   [Full Text] [Related]  

  • 43. A pharmacologically-based approach to high dose methotrexate administration to investigate nephrotoxicity and acute kidney injury biomarkers in children and adolescents with newly diagnosed osteosarcoma.
    Fox E; Busch C; DeBernardo A; Segers B; Gottschalk J; Womer R; Balamuth N; Bagatell R; Balis F
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):807-815. PubMed ID: 33677616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel risk factors for glucarpidase use in pediatric acute lymphoblastic leukemia: Hispanic ethnicity, age, and the ABCC4 gene.
    Zobeck MC; Bernhardt MB; Kamdar KY; Rabin KR; Lupo PJ; Scheurer ME
    Pediatr Blood Cancer; 2021 Aug; 68(8):e29036. PubMed ID: 33788417
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Toxicosis of high-dose methotrexate (HD-MTX) for osteosarcoma, cured with treatment by leucovorin (LV) rescue and hemoperfusion--a case report].
    Kobayashi H; Morita T; Hirata Y; Kato T; Okada Y; Sato T
    Gan To Kagaku Ryoho; 2000 Mar; 27(3):475-8. PubMed ID: 10740644
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resumption of high-dose methotrexate after methotrexate-induced nephrotoxicity and carboxypeptidase G2 use.
    Snyder RL
    Am J Health Syst Pharm; 2007 Jun; 64(11):1163-9. PubMed ID: 17519458
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Optimal management of methotrexate intoxication in a child with osteosarcoma.
    Peyriere H; Cociglio M; Margueritte G; Vallat C; Blayac JP; Hillaire-Buys D
    Ann Pharmacother; 2004 Mar; 38(3):422-7. PubMed ID: 14970366
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Renal failure after high-dose methotrexate in a child homozygous for MTHFR C677T polymorphism.
    Turello R; Rentsch K; Di Paolo E; Popovic MB
    Pediatr Blood Cancer; 2008 Jan; 50(1):154-6. PubMed ID: 17387702
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence and management of patients with methotrexate delayed elimination in the clinical practice: A Delphi study.
    Gros L; Roldán A; Cabero-Martínez A; Domínguez-Pinilla N; de la Fuente A; González-Barca E; Tasso M; Torrent M; Gallardo E; Del Cerro I; Giró-Perafita A; Badia X
    J Oncol Pharm Pract; 2023 Jun; 29(4):794-801. PubMed ID: 35147457
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Development of a novel nomogram for predicting delayed methotrexate excretion following high-dose methotrexate in adult patients with hematologic malignancies.
    Ikeda D; Isezaki T; Narita K; Yuyama S; Oura M; Uehara A; Tabata R; Takeuchi M; Matsue K
    Cancer Chemother Pharmacol; 2024 Sep; 94(3):397-406. PubMed ID: 38902559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
    Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
    Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes Associated with Reducing the Urine Alkalinization Threshold in Patients Receiving High-Dose Methotrexate.
    Drost SA; Wentzell JR; Giguère P; McLurg DL; Sabloff M; Kanji S; Nguyen TT
    Pharmacotherapy; 2017 Jun; 37(6):684-691. PubMed ID: 28394433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Substitution of l-leucovorin for d,l-leucovorin in the rescue from high-dose methotrexate treatment in patients with osteosarcoma.
    Jaffe N; Jorgensen K; Robertson R; George M; Letvak L; Barrett G
    Anticancer Drugs; 1993 Oct; 4(5):559-64. PubMed ID: 8292813
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
    Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
    Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early, empiric high-dose leucovorin rescue in lymphoma patients treated with sequential doses of high-dose methotrexate.
    Barreto JN; Peterson KT; Barreto EF; Mara KC; Dierkhising RA; Leung N; Witzig TE; Thompson CA
    Support Care Cancer; 2021 Sep; 29(9):5293-5301. PubMed ID: 33661366
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Severe acute toxicity associated with high-dose methotrexate (MTX) therapy: use of therapeutic drug monitoring and test-dose to guide carboxypeptidase G2 rescue and MTX continuation.
    Estève MA; Devictor-Pierre B; Galy G; André N; Coze C; Lacarelle B; Bernard JL; Monjanel-Mouterde S
    Eur J Clin Pharmacol; 2007 Jan; 63(1):39-42. PubMed ID: 17115148
    [No Abstract]   [Full Text] [Related]  

  • 58. Glucarpidase following high-dose methotrexate: update on development.
    Patterson DM; Lee SM
    Expert Opin Biol Ther; 2010 Jan; 10(1):105-11. PubMed ID: 19925307
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Successful treatment of high-dose methotrexate-induced oliguric acute renal failure by using a combination of hemodialysis filtration and direct hemoperfusion].
    Morozumi I; Inagaki A; Suzuki S; Sato Y; Ogura H; Suga N; Komatsu H; Wakita A; Yamada K
    Gan To Kagaku Ryoho; 2015 May; 42(5):609-11. PubMed ID: 25981656
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful rescue with leucovorin and thymidine in a patient with high-dose methotrexate induced acute renal failure.
    van den Bongard HJ; Mathĵt RA; Boogerd W; Schornagel JH; Soesan M; Schellens JH; Beijnen JH
    Cancer Chemother Pharmacol; 2001 Jun; 47(6):537-40. PubMed ID: 11459208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.